TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Adesso BioProducts AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
2,697,602
|
2,580,396
|
2,439,952 |
Financial expenses |
16,824
|
10,420
|
10,890 |
Earnings before taxes |
208,813
|
158,631
|
170,392 |
EBITDA |
220,511
|
170,121
|
182,691 |
Total assets |
838,494
|
853,676
|
801,246 |
Current assets |
821,419
|
836,862
|
783,822 |
Current liabilities |
246,829
|
307,012
|
359,260 |
Equity capital |
510,623
|
419,344
|
310,721 |
- share capital |
101
|
95
|
98 |
Employees (average) |
24
|
21
![]() |
21 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
60.9%
|
49.1%
|
38.8% |
Turnover per employee |
112,400
|
122,876
|
116,188 |
Profit as a percentage of turnover |
7.7%
|
6.1%
|
7.0% |
Return on assets (ROA) |
26.9%
|
19.8%
|
22.6% |
Current ratio |
332.8%
|
272.6%
|
218.2% |
Return on equity (ROE) |
40.9%
|
37.8%
|
54.8% |
Change turnover |
-65,891
|
213,774
|
577,054 |
Change turnover % |
-2%
|
9%
|
31% |
Chg. No. of employees |
3
|
0
|
1 |
Chg. No. of employees % |
14%
|
0%
|
5% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.